Literature DB >> 22298961

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis.

Asher Kornbluth1.   

Abstract

Entities:  

Year:  2011        PMID： 22298961      PMCID： PMC3265010     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.

Authors:  S Leblanc; M Allez; P Seksik; B Flourié; H Peeters; J L Dupas; G Bouguen; L Peyrin-Biroulet; B Duclos; A Bourreille; O Dewit; Y Bouhnik; P Michetti; S Chaussade; P Saussure; J Y Mary; J F Colombel; M Lémann
Journal:  Am J Gastroenterol       Date:  2011-03-08       Impact factor: 10.864

2.  Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.

Authors:  Elana A Maser; Deepthi Deconda; Simon Lichtiger; Thomas Ullman; Daniel H Present; Asher Kornbluth
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10       Impact factor: 11.382

3.  Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis.

Authors:  J W Huamán Ríos; F Casellas Jordá; J R Malagelada Benaprés
Journal:  Rev Esp Enferm Dig       Date:  2009-03       Impact factor: 2.086

Review 4.  Optimizing drug therapy in inflammatory bowel disease.

Authors:  Arun Swaminath; Asher Kornbluth
Journal:  Curr Gastroenterol Rep       Date:  2007-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.